Henry Schein, Inc. (0L3C.L)
USD 64.8
(1.84%)
USD 64.8
(1.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.42 Billion USD | 37.7% |
| 2022 | 3.93 Billion USD | -10.91% |
| 2021 | 4.41 Billion USD | 16.62% |
| 2020 | 3.78 Billion USD | 7.59% |
| 2019 | 3.52 Billion USD | -28.99% |
| 2018 | 4.95 Billion USD | -0.56% |
| 2017 | 4.98 Billion USD | 26.9% |
| 2016 | 3.92 Billion USD | 8.61% |
| 2015 | 3.61 Billion USD | 8.9% |
| 2014 | 3.32 Billion USD | 17.12% |
| 2013 | 2.83 Billion USD | 4.36% |
| 2012 | 2.71 Billion USD | 42.72% |
| 2011 | 1.9 Billion USD | 4.05% |
| 2010 | 1.83 Billion USD | 9.31% |
| 2009 | 1.67 Billion USD | 4.68% |
| 2008 | 1.59 Billion USD | 6.78% |
| 2007 | 1.49 Billion USD | 7.9% |
| 2006 | 1.38 Billion USD | 3.52% |
| 2005 | 1.34 Billion USD | 1.98% |
| 2004 | 1.31 Billion USD | 63.64% |
| 2003 | 803.72 Million USD | 16.47% |
| 2002 | 690.08 Million USD | -1.16% |
| 2001 | 698.18 Million USD | 8.41% |
| 2000 | 644.01 Million USD | -5.05% |
| 1999 | 678.3 Million USD | 37.56% |
| 1998 | 493.1 Million USD | 50.43% |
| 1997 | 327.8 Million USD | 96.52% |
| 1996 | 166.8 Million USD | 11.57% |
| 1995 | 149.5 Million USD | 0.61% |
| 1994 | 148.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.24 Billion USD | 2.68% |
| 2024 Q1 | 5.11 Billion USD | -5.72% |
| 2023 Q1 | 3.87 Billion USD | -1.55% |
| 2023 Q3 | 4.7 Billion USD | 13.74% |
| 2023 Q2 | 4.14 Billion USD | 6.84% |
| 2023 FY | 5.42 Billion USD | 37.7% |
| 2023 Q4 | 5.42 Billion USD | 15.1% |
| 2022 Q2 | 3.51 Billion USD | -16.86% |
| 2022 Q1 | 4.22 Billion USD | -4.41% |
| 2022 FY | 3.93 Billion USD | -10.91% |
| 2022 Q4 | 3.93 Billion USD | 5.64% |
| 2022 Q3 | 3.72 Billion USD | 6.12% |
| 2021 Q3 | 4.31 Billion USD | 4.8% |
| 2021 FY | 4.41 Billion USD | 16.62% |
| 2021 Q1 | 3.78 Billion USD | -0.13% |
| 2021 Q2 | 4.11 Billion USD | 8.83% |
| 2021 Q4 | 4.41 Billion USD | 2.38% |
| 2020 Q1 | 3.91 Billion USD | 11.15% |
| 2020 Q2 | 3.69 Billion USD | -5.54% |
| 2020 Q3 | 4.01 Billion USD | 8.69% |
| 2020 Q4 | 3.78 Billion USD | -5.71% |
| 2020 FY | 3.78 Billion USD | 7.59% |
| 2019 Q1 | 3.73 Billion USD | -24.78% |
| 2019 FY | 3.52 Billion USD | -28.99% |
| 2019 Q2 | 3.66 Billion USD | -1.72% |
| 2019 Q3 | 3.63 Billion USD | -0.77% |
| 2019 Q4 | 3.52 Billion USD | -3.21% |
| 2018 Q3 | 4.97 Billion USD | 8.27% |
| 2018 Q2 | 4.59 Billion USD | -8.18% |
| 2018 Q1 | 5 Billion USD | 20.42% |
| 2018 FY | 4.95 Billion USD | -0.56% |
| 2018 Q4 | 4.95 Billion USD | -0.3% |
| 2017 Q1 | 4.04 Billion USD | 3.04% |
| 2017 FY | 4.98 Billion USD | 26.9% |
| 2017 Q4 | 4.15 Billion USD | -6.98% |
| 2017 Q3 | 4.46 Billion USD | 7.29% |
| 2017 Q2 | 4.16 Billion USD | 2.81% |
| 2016 Q4 | 3.92 Billion USD | 5.34% |
| 2016 Q2 | 3.67 Billion USD | -0.17% |
| 2016 Q1 | 3.68 Billion USD | 1.84% |
| 2016 FY | 3.92 Billion USD | 8.61% |
| 2016 Q3 | 3.73 Billion USD | 1.43% |
| 2015 Q4 | 3.61 Billion USD | 5.49% |
| 2015 FY | 3.61 Billion USD | 8.9% |
| 2015 Q3 | 3.42 Billion USD | 5.86% |
| 2015 Q2 | 3.23 Billion USD | 1.13% |
| 2015 Q1 | 3.2 Billion USD | -3.58% |
| 2014 Q2 | 3.13 Billion USD | 2.52% |
| 2014 Q3 | 3.3 Billion USD | 5.46% |
| 2014 Q4 | 3.32 Billion USD | 0.39% |
| 2014 Q1 | 3.06 Billion USD | 7.91% |
| 2014 FY | 3.32 Billion USD | 17.12% |
| 2013 FY | 2.83 Billion USD | 4.36% |
| 2013 Q4 | 2.83 Billion USD | 10.5% |
| 2013 Q3 | 2.56 Billion USD | 0.79% |
| 2013 Q2 | 2.54 Billion USD | -3.01% |
| 2013 Q1 | 2.62 Billion USD | -3.39% |
| 2012 Q1 | 1.86 Billion USD | -2.17% |
| 2012 Q3 | 2.16 Billion USD | 8.9% |
| 2012 Q2 | 1.98 Billion USD | 6.6% |
| 2012 FY | 2.71 Billion USD | 42.72% |
| 2012 Q4 | 2.71 Billion USD | 25.68% |
| 2011 Q2 | 1.88 Billion USD | -1.87% |
| 2011 FY | 1.9 Billion USD | 4.05% |
| 2011 Q4 | 1.9 Billion USD | 3.47% |
| 2011 Q3 | 1.84 Billion USD | -2.34% |
| 2011 Q1 | 1.92 Billion USD | 4.94% |
| 2010 Q2 | 2.15 Billion USD | 3.84% |
| 2010 FY | 1.83 Billion USD | 9.31% |
| 2010 Q1 | 2.07 Billion USD | 23.68% |
| 2010 Q4 | 1.83 Billion USD | -18.15% |
| 2010 Q3 | 2.23 Billion USD | 3.99% |
| 2009 FY | 1.67 Billion USD | 4.68% |
| 2009 Q2 | 1.47 Billion USD | 4.49% |
| 2009 Q3 | 1.62 Billion USD | 10.54% |
| 2009 Q4 | 1.67 Billion USD | 2.78% |
| 2009 Q1 | 1.41 Billion USD | -11.83% |
| 2008 FY | 1.59 Billion USD | 6.78% |
| 2008 Q4 | 1.59 Billion USD | 6.05% |
| 2008 Q1 | 1.46 Billion USD | -2.37% |
| 2008 Q2 | 1.49 Billion USD | 2.12% |
| 2008 Q3 | 1.5 Billion USD | 0.98% |
| 2007 Q3 | 1.58 Billion USD | 21.12% |
| 2007 FY | 1.49 Billion USD | 7.9% |
| 2007 Q1 | 1.28 Billion USD | -7.5% |
| 2007 Q2 | 1.3 Billion USD | 1.58% |
| 2007 Q4 | 1.49 Billion USD | -5.2% |
| 2006 Q4 | 1.38 Billion USD | 7.27% |
| 2006 FY | 1.38 Billion USD | 3.52% |
| 2006 Q3 | 1.29 Billion USD | 1.28% |
| 2006 Q2 | 1.27 Billion USD | 1.93% |
| 2006 Q1 | 1.25 Billion USD | -6.52% |
| 2005 FY | 1.34 Billion USD | 1.98% |
| 2005 Q2 | 1.26 Billion USD | 5.38% |
| 2005 Q3 | 1.27 Billion USD | 0.58% |
| 2005 Q4 | 1.34 Billion USD | 5.57% |
| 2005 Q1 | 1.19 Billion USD | -8.86% |
| 2004 Q2 | 1.13 Billion USD | 43.91% |
| 2004 Q4 | 1.31 Billion USD | 15.21% |
| 2004 Q3 | 1.14 Billion USD | 0.28% |
| 2004 Q1 | 791.1 Million USD | -1.57% |
| 2004 FY | 1.31 Billion USD | 63.64% |
| 2003 FY | 803.72 Million USD | 16.47% |
| 2003 Q4 | 803.72 Million USD | 9.38% |
| 2003 Q3 | 734.82 Million USD | 5.38% |
| 2003 Q1 | 650.89 Million USD | -5.68% |
| 2003 Q2 | 697.31 Million USD | 7.13% |
| 2002 Q2 | 625.34 Million USD | 5.18% |
| 2002 Q3 | 689.85 Million USD | 10.32% |
| 2002 Q4 | 690.08 Million USD | 0.03% |
| 2002 FY | 690.08 Million USD | -1.16% |
| 2002 Q1 | 594.55 Million USD | -14.84% |
| 2001 Q1 | 576.87 Million USD | -10.42% |
| 2001 Q4 | 698.18 Million USD | 12.45% |
| 2001 FY | 698.18 Million USD | 8.41% |
| 2001 Q3 | 620.87 Million USD | 7.94% |
| 2001 Q2 | 575.22 Million USD | -0.29% |
| 2000 Q3 | 624.79 Million USD | 0.4% |
| 2000 Q4 | 644.01 Million USD | 3.08% |
| 2000 Q1 | 638.98 Million USD | -5.8% |
| 2000 Q2 | 622.29 Million USD | -2.61% |
| 2000 FY | 644.01 Million USD | -5.05% |
| 1999 FY | 678.3 Million USD | 37.56% |
| 1999 Q4 | 678.3 Million USD | 2.37% |
| 1999 Q3 | 662.6 Million USD | 1.38% |
| 1999 Q2 | 653.6 Million USD | -1.04% |
| 1999 Q1 | 660.5 Million USD | 33.95% |
| 1998 Q1 | 334.5 Million USD | 2.04% |
| 1998 Q3 | 491.4 Million USD | 24.22% |
| 1998 Q4 | 493.1 Million USD | 0.35% |
| 1998 FY | 493.1 Million USD | 50.43% |
| 1998 Q2 | 395.6 Million USD | 18.27% |
| 1997 Q2 | 177.8 Million USD | 27.09% |
| 1997 FY | 327.8 Million USD | 96.52% |
| 1997 Q4 | 327.8 Million USD | 17.24% |
| 1997 Q1 | 139.9 Million USD | -16.13% |
| 1997 Q3 | 279.6 Million USD | 57.26% |
| 1996 Q4 | 166.8 Million USD | 12.25% |
| 1996 Q1 | 154.3 Million USD | 3.21% |
| 1996 Q2 | 136.8 Million USD | -11.34% |
| 1996 Q3 | 148.6 Million USD | 8.63% |
| 1996 FY | 166.8 Million USD | 11.57% |
| 1995 Q4 | 149.5 Million USD | 0.0% |
| 1995 FY | 149.5 Million USD | 0.61% |
| 1994 FY | 148.6 Million USD | 0.0% |
| 1994 Q4 | 148.6 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -4430.409% |
| Accuray Incorporated | 423.54 Million USD | -1179.681% |
| Align Technology, Inc. | 2.45 Billion USD | -120.919% |
| Elevance Health Inc. | 69.52 Billion USD | 92.204% |
| AxoGen, Inc. | 101.16 Million USD | -5257.743% |
| Boston Scientific Corporation | 15.6 Billion USD | 65.27% |
| CVS Health Corporation | 173.09 Billion USD | 96.869% |
| Cardinal Health, Inc. | 48.33 Billion USD | 88.786% |
| Centene Corporation | 58.68 Billion USD | 90.764% |
| DaVita Inc. | 14.87 Billion USD | 63.566% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 90.172% |
| Hologic, Inc. | 4.02 Billion USD | -34.625% |
| Humana Inc. | 30.74 Billion USD | 82.372% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -205.284% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 38.65% |
| Masimo Corporation | 1.67 Billion USD | -223.254% |
| McKesson Corporation | 69.04 Billion USD | 92.15% |
| Patterson Companies, Inc. | 1.89 Billion USD | -186.016% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 28.722% |
| ResMed Inc. | 2 Billion USD | -169.873% |
| Teladoc Health, Inc. | 2.06 Billion USD | -162.305% |
| Universal Health Services, Inc. | 8.15 Billion USD | 33.537% |
| Veeva Systems Inc. | 1.26 Billion USD | -328.088% |
| Baxter International Inc. | 19.8 Billion USD | 72.637% |
| Becton, Dickinson and Company | 26.98 Billion USD | 79.914% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -165.14% |
| Danaher Corporation | 30.99 Billion USD | 82.515% |
| Stryker Corporation | 21.31 Billion USD | 74.577% |
| Medtronic plc | 39.56 Billion USD | 86.3% |